Early Phase 1 Transplantation Clinical Trials
6 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–6 of 6 trials
Recruiting
Early Phase 1
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
Allogeneic Hematopoietic Stem Cell Transplantation RecipientAdenovirusCytomegalovirus+2 more
Sumithira Vasu20 enrolled2 locationsNCT03665675
Recruiting
Early Phase 1
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
Allogeneic Hematopoietic Cell Transplantation
Case Comprehensive Cancer Center20 enrolled1 locationNCT04332341
Recruiting
Early Phase 1
Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients
Hematopoietic Stem Cell TransplantationGraft Failure
Children's Hospital Medical Center, Cincinnati20 enrolled1 locationNCT07244419
Recruiting
Early Phase 1
Tolerance Through Mixed Chimerism (Sip-Tego)
Kidney FailureTransplant Recipient (Kidney)Immunosuppresion+2 more
Tatsuo Kawai, MD, PhD12 enrolled1 locationNCT06972069
Recruiting
Early Phase 1
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion
University of Arizona100 enrolled1 locationNCT06643221
Not Yet Recruiting
Early Phase 1
Everolimus for the prevention of calcineurin-inhibitor-induced left ventricular hypertrophy in heart transplantation
Left ventricular hypertrophy in heart transplantation
St. Vincent`s Hospital40 enrolled4 locationsACTRN12614000387628